Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 20.40
-0.50 (-2.39%)
Aug 28, 2026, 1:44 PM IDT
Bonus BioGroup Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23.87 | -24.49 | -27.83 | -28.53 | -38.7 | -90.08 |
Depreciation & Amortization | 2.75 | 2.76 | 2.79 | 2.76 | 2.66 | 1.48 |
Loss (Gain) From Sale of Investments | - | - | - | - | 7.9 | 20.98 |
Stock-Based Compensation | 1.04 | 1.46 | 1.63 | 1.45 | 7.6 | 9.85 |
Other Operating Activities | 0.12 | 0.07 | -0.05 | -0.75 | -6.93 | 26.34 |
Change in Accounts Receivable | -0.11 | -0.69 | 0.13 | 0.35 | 0.36 | -0.52 |
Change in Accounts Payable | 0.91 | 1.05 | -0.47 | -0.38 | -2.35 | 2.44 |
Change in Other Net Operating Assets | 4.05 | 4.91 | 2.42 | -1.3 | 0.64 | -10.33 |
Operating Cash Flow | -15.11 | -14.93 | -21.37 | -26.4 | -28.82 | -39.84 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.04 | -0.01 | -0.34 | -0.82 | -6.39 | -5.81 |
Investment in Securities | - | - | 13 | -13.43 | - | - |
Other Investing Activities | - | - | - | - | 0.1 | -0.37 |
Investing Cash Flow | -0.04 | -0.01 | 12.65 | -14.26 | -6.29 | -6.18 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -1.49 | -1.3 | -1.16 | -1.2 | -1.65 |
Total Debt Repaid | -1.56 | -1.49 | -1.3 | -1.16 | -1.2 | -1.65 |
Net Debt Issued (Repaid) | -1.56 | -1.49 | -1.3 | -1.16 | -1.2 | -1.65 |
Issuance of Common Stock | 16.11 | 9.91 | 3.85 | - | 3.34 | 111.35 |
Other Financing Activities | - | - | - | - | - | 3.72 |
Financing Cash Flow | 14.54 | 8.42 | 2.55 | -1.16 | 2.14 | 113.42 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.16 | -0.1 | 0.09 | 1.12 | 7.05 | -3.94 |
Net Cash Flow | -0.76 | -6.63 | -6.08 | -40.69 | -25.93 | 63.46 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -15.15 | -14.95 | -21.72 | -27.22 | -35.2 | -45.65 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | - | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 |
Levered Free Cash Flow | -5.77 | -6.32 | -11.84 | -17.26 | -20.47 | -44.15 |
Unlevered Free Cash Flow | -5.33 | -5.88 | -11.35 | -16.73 | -19.91 | -43.8 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.72 | 0.72 | 0.8 | 0.86 | 0.9 | 0.34 |
Change in Working Capital | 4.84 | 5.27 | 2.08 | -1.33 | -1.35 | -8.41 |